20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Oscar Health Inc (OSCR) operates in the HEALTHCARE PLANS industry and is headquartered in New York, United States with about 2,305 employees. Its market capitalization is roughly $10 billion. In the fiscal year ended 2025-12-31, OSCR reported $11.7B in revenue and ($443M) in net income.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets.
Interactive charts & full statements → Open the OSCR valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $15.3B | $11.7B | $9.2B | $5.9B | $4.1B | $1.9B | $590M | $554M |
| Gross Profit | — | $1.7B | $1.8B | $5.9B | $4.1B | $1.9B | $590M | $554M |
| Gross Margin % | — | 14.4% | 20.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income (EBIT) | — | ($396M) | $57M | ($236M) | ($610M) | ($571M) | ($406M) | ($259M) |
| Operating Margin % | — | -3.4% | 0.6% | -4.0% | -14.8% | -29.7% | -68.8% | -46.8% |
| Net Income | $551M | ($443M) | $25M | ($271M) | ($606M) | ($573M) | ($407M) | ($261M) |
| Net Margin % | 3.6% | -3.8% | 0.3% | -4.6% | -14.7% | -29.8% | -69.0% | -47.2% |
| EBITDA | — | ($391M) | $89M | ($236M) | ($572M) | ($551M) | ($391M) | ($252M) |
| Earnings Per Share (EPS) | $1.39 | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-13.90 | $-9.06 |
| Shares Outstanding (M) | — | 262M | 266M | 222M | 212M | 179M | 29M | 29M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $4.9B | $4.6B | $2.8B | $3.0B | $2.9B | $3.0B | $2.4B | $2.4B | $2.2B |
| Gross Profit | — | $1.4B | $185M | $400M | $311M | $787M | $327M | $2.4B | $2.2B |
| Gross Margin % | — | 30.5% | 6.6% | 13.4% | 10.9% | 25.8% | 13.7% | 100.0% | 100.0% |
| Operating Income (EBIT) | — | $704M | ($334M) | ($129M) | ($230M) | $297M | ($148M) | ($52M) | $61M |
| Operating Margin % | — | 15.2% | -11.9% | -4.3% | -8.1% | 9.8% | -6.2% | -2.2% | 2.8% |
| Net Income | $362M | $679M | ($353M) | ($137M) | ($228M) | $275M | ($154M) | ($55M) | $56M |
| Net Margin % | 7.4% | 14.6% | -12.6% | -4.6% | -8.0% | 9.0% | -6.4% | -2.2% | 2.5% |
| EBITDA | — | $711M | ($346M) | ($125M) | ($221M) | $301M | ($138M) | ($39M) | $75M |
| Earnings Per Share (EPS) | $1.10 | $2.06 | $-1.24 | $-0.53 | $-0.85 | $0.90 | $-0.58 | $-0.22 | $0.18 |
| Shares Outstanding (M) | — | 330M | 283M | 259M | 270M | 306M | 266M | 243M | 304M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $4.4B | $1.1B | $978M | ($272M) | $380M | ($182M) | $223M | ($165M) |
| Capital Expenditures (CapEx) | $39M | $36M | $28M | $26M | $29M | $26M | $14M | $26M |
| Free Cash Flow (FCF) | $4.4B | $1.1B | $950M | ($298M) | $351M | ($208M) | $209M | ($191M) |
| FCF Margin % | 28.6% | 9.0% | 10.3% | -5.1% | 8.5% | -10.8% | 35.4% | -34.6% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $2.1B | $2.6B | $672M | ($965M) | $509M | $879M | $347M | ($500M) | $497M |
| Capital Expenditures (CapEx) | $12M | $9M | $9M | $9M | $9M | $9M | $7M | $8M | $8M |
| Free Cash Flow (FCF) | $2.1B | $2.6B | $663M | ($974M) | $500M | $870M | $340M | ($508M) | $490M |
| FCF Margin % | 42.6% | 56.2% | 23.6% | -32.6% | 17.4% | 28.5% | 14.2% | -20.9% | 22.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.2B | $6.3B | $4.8B | $3.6B | $4.5B | $3.3B | $2.3B | $1.3B |
| Cash & Cash Equivalents | $4.1B | $2.8B | $1.5B | $1.9B | $1.6B | $1.1B | $826M | $337M |
| Total Liabilities | $9.2B | $5.3B | $3.8B | $2.8B | $3.6B | $1.9B | $3.6B | $494M |
| Total Debt (Short + Long-Term) | $432M | $430M | $300M | $299M | $298M | $0M | $142M | $0M |
| Total Shareholders' Equity | $2.1B | $978M | $1.0B | $804M | $890M | $1.4B | ($1.3B) | $853M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OSCR viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms